Literature DB >> 19760042

Decreased paraoxonase activity in critically ill patients with sepsis.

Frantisek Novak1, Lucie Vavrova, Jana Kodydkova, Frantisek Novak1, Magdalena Hynkova, Ales Zak, Olga Novakova.   

Abstract

Paraoxonase 1 is believed to play a role in preventing lipid oxidation and, thus, limiting production of proinflammatory mediators. Systemic inflammatory response in sepsis increases oxidative stress and decreases high-density lipoprotein (HDL) concentrations. The objective of this study was to investigate serum paraoxonase 1 activities in critically ill patients with sepsis and after recovery. Serum paraoxonase 1 arylesterase/paraoxonase activities, concentration of total cholesterol, HDL cholesterol (HDL-C) and serum C-reactive protein (CRP) in septic patients of a medical intensive care unit (n = 30) and age/sex-matched outpatient controls without sepsis (n = 30) were analyzed. Paired convalescent samples were also taken 1 week after recovery (n = 11). In septic patients, both arylesterase (88.3 +/- 36.5 vs. 162.1 +/- 44.8 kU/l, P < 0.001) and paraoxonase (75.2 +/- 50.0 vs. 125.2 +/- 69.4 U/l, P < 0.01) paraoxonase 1 activities decreased as compared to controls. Both activities normalized after recovery. Negative correlation was found between CRP and both arylesterase (r = -0.676, P < 0.001) and paraoxonase (r = -0.401, P < 0.01) as well as positive correlation between HDL-C and both arylesterase (r = 0.585, P < 0.001) and paraoxonase (r = 0.405, P < 0.01) paraoxonase 1 activities. The decreased activity of paraoxonase 1 in negative correlation with CRP offers a potentially useful marker of sepsis progress and recovery in critically ill patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19760042     DOI: 10.1007/s10238-009-0059-8

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  22 in total

Review 1.  Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations.

Authors:  R A Balk
Journal:  Crit Care Clin       Date:  2000-04       Impact factor: 3.598

2.  Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection.

Authors:  Sandra Parra; Carlos Alonso-Villaverde; Blai Coll; Natàlia Ferré; Judit Marsillach; Gerard Aragonès; Michael Mackness; Bharti Mackness; Lluis Masana; Jorge Joven; Jordi Camps
Journal:  Atherosclerosis       Date:  2006-08-30       Impact factor: 5.162

3.  Lipids, lipoproteins, and apoproteins in serum during infection.

Authors:  C Alvarez; A Ramos
Journal:  Clin Chem       Date:  1986-01       Impact factor: 8.327

4.  The human serum paraoxonase/arylesterase polymorphism.

Authors:  H W Eckerson; C M Wyte; B N La Du
Journal:  Am J Hum Genet       Date:  1983-11       Impact factor: 11.025

5.  Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.

Authors:  B J Van Lenten; S Y Hama; F C de Beer; D M Stafforini; T M McIntyre; S M Prescott; B N La Du; A M Fogelman; M Navab
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  Serum paraoxonase-1 activity in Helicobacter pylori infected subjects.

Authors:  Mehmet Aslan; Yasar Nazligul; Mehmet Horoz; Cengiz Bolukbas; Fusun F Bolukbas; Mustafa Gur; Hakim Celik; Ozcan Erel
Journal:  Atherosclerosis       Date:  2006-11-27       Impact factor: 5.162

7.  Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response.

Authors:  K R Feingold; R A Memon; A H Moser; C Grunfeld
Journal:  Atherosclerosis       Date:  1998-08       Impact factor: 5.162

8.  Lipoprotein metabolism in patients with severe sepsis.

Authors:  Henk J van Leeuwen; Eric C J M Heezius; Geesje M Dallinga; Jos A G van Strijp; Jan Verhoef; Kok P M van Kessel
Journal:  Crit Care Med       Date:  2003-05       Impact factor: 7.598

9.  Paraoxonase-1 status in Crohn's disease and ulcerative colitis.

Authors:  Dorota Boehm; Malgorzata Krzystek-Korpacka; Katarzyna Neubauer; Malgorzata Matusiewicz; Izabela Berdowska; Bogdan Zielinski; Leszek Paradowski; Andrzej Gamian
Journal:  Inflamm Bowel Dis       Date:  2009-01       Impact factor: 5.325

10.  Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock.

Authors:  Paulo Sergio Martins; Esper Georges Kallas; Miguel Cendoroglo Neto; Maria Aparecida Dalboni; Sérgio Blecher; Reinaldo Salomão
Journal:  Shock       Date:  2003-09       Impact factor: 3.454

View more
  25 in total

Review 1.  Paraoxonases as protective agents against N-acyl homoserine lactone - producing pathogenic microorganisms.

Authors:  Bogdan Nicolae Manolescu
Journal:  Maedica (Bucur)       Date:  2013-03

2.  Evaluation of oxidative stress status and antioxidant capacity in patients with painful bladder syndrome/interstitial cystitis: preliminary results of a randomised study.

Authors:  Kemal Ener; Murat Keske; Mustafa Aldemir; Muhammet Fuat Özcan; Emrah Okulu; Asım Özayar; Merve Ergin; Ömer Gökhan Doluoğlu; Serdar Çakmak; Özcan Erel
Journal:  Int Urol Nephrol       Date:  2015-06-07       Impact factor: 2.370

3.  Preanalytical variables affecting the measurement of serum paraoxonase-1 activity in horses.

Authors:  Gabriele Rossi; Amy Richardson; Hali Jamaludin; Cristy Secombe
Journal:  J Vet Diagn Invest       Date:  2020-11-22       Impact factor: 1.279

4.  Plasma Phospholipid Fatty Acid Profile is Altered in Both Septic and Non-Septic Critically Ill: A Correlation with Inflammatory Markers and Albumin.

Authors:  František Novak; J Borovska; M Vecka; J Rychlikova; L Vavrova; H Petraskova; A Zak; O Novakova
Journal:  Lipids       Date:  2016-12-30       Impact factor: 1.880

5.  Paraoxonase 1 Activity and Survival in Sepsis Patients.

Authors:  Volkan İnal; Levent Yamanel; Gürhan Taşkın; Serkan Tapan; Bilgin Cömert
Journal:  Balkan Med J       Date:  2015-04-01       Impact factor: 2.021

6.  Increased inflammatory markers with altered antioxidant status persist after clinical recovery from severe sepsis: a correlation with low HDL cholesterol and albumin.

Authors:  Lucie Vavrova; Jana Rychlikova; Magdalena Mrackova; Olga Novakova; Ales Zak; Frantisek Novak
Journal:  Clin Exp Med       Date:  2015-09-28       Impact factor: 3.984

7.  Serum paraoxonase 1 activity in cats: analytical validation, reference intervals, and correlation with serum amyloid A and alpha-1-acid glycoprotein.

Authors:  Gabriele Rossi; Sara Meazzi; Alessia Giordano; Saverio Paltrinieri
Journal:  J Vet Diagn Invest       Date:  2020-08-17       Impact factor: 1.279

8.  Paraoxonase (PON1) activity in patients with subclinical thoracic aortic atherosclerosis.

Authors:  Mustafa Gür; Murat Çaylı; Hakan Uçar; Zafer Elbasan; Durmuş Yıldıray Şahin; Mehmet Yavuz Gözükara; Şahbettin Selek; Nermin Yıldız Koyunsever; Taner Şeker; Caner Türkoğlu; Onur Kaypaklı; Nurten Aksoy
Journal:  Int J Cardiovasc Imaging       Date:  2014-04-04       Impact factor: 2.357

9.  Ischemia-Modified Albumin, Creatinine, And Paraoxonase-1 Levels in Serum of Patients Undergoing Intravenous Contrast-Enhanced Computed Tomography and Its Association with Contrast-Induced Nephropathy.

Authors:  Chanda Jha; Shobha Ullas Kamath; Sambit Dash; Ravindra Prabhu Attur; Lingadakai Ramachandra; Rajgopal Shenoy Kallya
Journal:  Rep Biochem Mol Biol       Date:  2019-04

Review 10.  The Endothelium Is Both a Target and a Barrier of HDL's Protective Functions.

Authors:  Jérôme Robert; Elena Osto; Arnold von Eckardstein
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.